QI
ORTX

QS Investors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

QS Investors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$475K Buy
10,800
+9,500
+731% +$529K 0.01% 752
2021
Q1 		$95K Buy
+1,300
New +$92.3K ﹤0.01% 1156

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

QS Investors's ORTX Position: Q2 2021 in Review

QS Investors increased its Orchard Therapeutics plc American Depositary Shares (ORTX) stake by 731% in Q2 2021, buying an estimated $529K and bringing the position to 10,800 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #752.

QS Investors first reported a position in ORTX in Q1 2021 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold ORTX as of Q2 2021.

  • QS Investors held 10,800 shares of Orchard Therapeutics plc American Depositary Shares worth $475K as of Q2 2021.
  • QS Investors bought 9,500 Orchard Therapeutics plc American Depositary Shares shares in Q2 2021, an estimated $529K.
  • Orchard Therapeutics plc American Depositary Shares made up 0.01% of QS Investors's portfolio in Q2 2021, its #752 holding.
  • QS Investors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and has held it in 2 quarters since.
  • 85 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.